Biological psychiatry : proceedings of the 5th World Congress of Biological Psychiatry, Florence, 9-14 June 1991

書誌事項

Biological psychiatry : proceedings of the 5th World Congress of Biological Psychiatry, Florence, 9-14 June 1991

editors, Giorgio Racagni, Nicoletta Brunello, Tetsuo Fukuda

(International congress series, no. 968)

Excerpta Medica, 1991

  • v. 1
  • v. 2

この図書・雑誌をさがす
注記

Includes bibliographical references and indexes

内容説明・目次
巻冊次

v. 1 ISBN 9780444814104

内容説明

Biological psychology represents a fusion of several scientific disciplines - pharmacology, neurobiology, biochemistry, genetics, physiology, anatomy, biophysics and psychology. All are focussed on acquiring an ultimate understanding of the relationships between brain and behaviour. Presented in two volumes are the papers of the 5th World Congress of Biological Psychiatry. Together they represent a significant contribution to complementary advances across a broad front of recently developed research areas. Psychiatric disorders include schizophrenia, affective disorders, the many forms of senile and presenile dementia including Alzheimer's disease, the anxiety disorders, childhood disorders and the variants of eating and sleeping dysfunctions. Each of these illnesses represents a complex interaction of biological, psychological and social variables. The growing number of neuroscientists adopting the biological approach to neuropsychiatric diseases has resulted in a fast expanding body of knowledge regarding brain function and pathology. Further, psychotherapeutic drugs used to treat psychiatric and neurologic disorders play a crucial role in elucidating the biological bases of these diseases. Studying the mechanism of action of these compounds should give us important clues about the normal and pathological functioning of the brain.

目次

DIAGNOSIS AND CLASSIFICATION. Developing DSM-IV: A preview of the future (3 papers). Classification of depression: from biology to nosology (5 papers). Diagnostic specificity - A useful guide to biological psychiatry? (5 papers). AFFECTIVE DISORDERS: CLINICAL AND BIOLOGICAL RESEARCH. Clinical indices of vulnerability for depression (3 papers). Prophylaxis of affective disorders (4 papers). Biological markers in depression (6 papers). PET and SPECT studies of blood flow/metabolism in affective disorders (2 papers). Biological studies of suicide risk (6 papers). Neurobiology and pharmacotherapy of suicidal behaviour (5 papers). Dysthymia and minor depressive disorder: Diagnosis and treatment possibilities (3 papers). Biological mechanisms in post partum mental illness (4 papers). Depression and stress: Pathophysiological and therapeutic aspects (4 papers). Second messenger transduction in the pathogenesis and treatment of affective disorders (7 papers). The influence of mood stabilizing drugs on cerebral second messenger systems (4 papers). Circadian rhythms in affective disorders: New concepts, novel therapies (2 papers). HPA regulation in depression (5 papers). Pain and depression (9 papers). Optimization of therapeutic outcome with ECT (5 papers). Serotonin uptake inhibitors in depression and other indications (7 papers). Present status on the mode of action of antidepressant drugs (5 papers). New antidepressants: Novel approaches and their implications (5 papers). Onset of action of antidepressant activity: Biological and clinical aspects (6 papers). Lithium potentiation of tricyclic antidepressants: Clinical efficacy and basic machanisms (4 papers). Pharmacokinetics of tricyclic antidepressants and MAO-inhibitors (6 papers). Selective reversible MAO inhibitors as antidepressants (7 papers). Renaissance of MAOIs: The new selective and reversible generation (5 papers). New findings in child psychiatry (4 papers). SCHIZOPHRENIA AND RELATED DISORDERS: CLINICAL AND BIOLOGICAL STUDIES. Epidemiology of schizophrenia (5 papers). Clinical and neurobiological heterogeneity of schizophrenic psychoses (6 papers). Cognitive disturbance and cerebral dysfunction of schizophrenics (4 papers). Cerebral blood flow or metabolic patterns (PET/SPECT) during cognition in schizophrenia (1 paper). Post mortem brain studies in schizophrenia (7 papers). The neuroanatomy of schizophrenia (4 papers). Neurotransmitters in schizophrenia (3 papers). Serotonergic mechanisms in schizophrenia (4 papers). Psychophysiological approaches to schizophrenia (4 papers). Modern trends in the treatment of chronic schizophrenia (4 papers). Mechanism of action of atypical antipsychotic drugs (4 papers). Psychopathological side effects of long-term administration of neuroleptics (6 papers). Tardive dyskinesia: Preclinical and clinical studies (10 papers). STRESS, ANXIETY AND PERSONALITY DISORDERS: PATHOPHYSIOLOGY, BIOLOGY AND TREATMENT ISSUES. Post- traumatic stress disorder (2 papers).
巻冊次

v. 2 ISBN 9780444892959

内容説明

Biological psychology represents a fusion of several scientific disciplines - pharmacology, neurobiology, biochemistry, genetics, physiology, anatomy, biophysics and psychology. All are focussed on acquiring an ultimate understanding of the relationships between brain and behaviour. Presented in two volumes are the papers of the 5th World Congress of Biological Psychiatry. Together they represent a significant contribution to complementary advances across a broad front of recently developed research areas. Psychiatric disorders include schizophrenia, affective disorders, the many forms of senile and presenile dementia including Alzheimer's disease, the anxiety disorders, childhood disorders and the variants of eating and sleeping dysfunctions. Each of these illnesses represents a complex interaction of biological, psychological and social variables. The growing number of neuroscientists adopting the biological approach to neuropsychiatric diseases has resulted in a fast expanding body of knowledge regarding brain function and pathology. Further, psychotherapeutic drugs used to treat psychiatric and neurologic disorders play a crucial role in elucidating the biological bases of these diseases. Studying the mechanism of action of these compounds should give us important clues about the normal and pathological functioning of the brain.

目次

ALCOHOLISM, DRUG DEPENDENCE AND ABUSE. Alcoholism: Molecular mechanism and new treatments (5 papers). Clinical neurophysiology of substance abuse (3 papers). Neurobiology of drug addiction (4 papers). New strategies in pharmacological treatment of substance abuse disorders (5 papers). Developmental neurobehavioural effects of psychotropic drugs and drugs abuse (5 papers). AGING AND DEMENTIA: CLINICAL AND BIOLOGICAL RESEARCH. HIV-1 associated dementia (6 papers). Cognitive impairment in psychiatric diseases: Basic and clinical investigations (4 papers). Neuroimmunomodulation in ageing (1 paper). Neurobiology of ageing and Alzheimer disease (14 papers). Pharmacological treatment of mental and cognitive disorders in ageing (3 papers). ANTICONVULSANTS, EPILEPSY AND ORGANIC MENTAL DISORDERS. Pharmacotherapy of brain lesions (6 papers). Biological basis of ictal, perictal and interictal behavioural changes in epilepsy (5 papers). Kindling, psychiatry and anticonvulsant drugs (4 papers). Limbic system surgery in the treatment of severe refractory psychiatric illness (8 papers). Carbamazepine and other anticonvulsants in the treatment of psychiatric disorders (6 papers). EATING DISORDERS: BASIC AND CLINICAL RESEARCH. Neuronal basis of eating behaviour and appetite disorder: Organization of the system (5 papers). Clinical aspects of bulimia nervosa (6 papers). Psychobiology of eating disorders (6 papers). BIOLOGICAL MARKERS, BRAIN IMAGING, EVOKED POTENTIALS AND EEG MAPPING. Plasma amino acids: Markers, predictors, therapeutical tools for psychiatric disease (4 papers). Plasma dexamethazone and the DST (3 papers). Platelets: Useful tools in neuropsychiatric disorders (4 papers). Magnetic resonance imaging and psychoses (6 papers). Brain receptor imaging in psychoses (2 papers). EEG functional mapping: Disease and treatment states (4 papers). Event related potentials in psychiatry (5 papers). Pharmaco-EEG and EEG mapping (4 papers). GENETICS IN PSYCHIATRY: BASIC AND CLINICAL ASPECTS. Transgenic animals as experimental models in neuroimmunology (1 paper). Molecular genetics of affective illnesses (4 papers). Molecular genetics of psychoses (5 papers). The X chromosome in psychiatric diseases (6 papers). Cytogenetics of psychiatric disease (3 papers). Continuity or discontinuity in psychotic illness: Kraepelin versus his antagonists (3 papers). NEUROPEPTIDES AND PSYCHONEUROIMMUNOENDOCRINOLOGY. Psychotropic actions of non-peptidergic hormones: Clinical and basic sciences perspectives (2 papers). An appraisal of use of neuropeptides as putative therapeutic agents in brain disorders (4 papers). Peptides - Relevance for psychiatric disorders (4 papers). Role of neuropeptides in the pathogenesis of affective disorders (5 papers). Immunological aspects of psychiatric disorders (1 paper). Psychoneuroimmunoendocrinology: A new research pathway (6 papers). NEUROTRANSMITTERS, RECEPTOR MOLECULAR BIOLOGY, BRAIN SIGNAL TRANSDUCTIONS AND BEHAVIOUR.

「Nielsen BookData」 より

関連文献: 1件中  1-1を表示
詳細情報
ページトップへ